Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss

Research output: Contribution to journal › Journal article › Research › peer-review

Presentation
Citation formats

Rune Rasmussen
Magnus Claesson
Sven-Eric Stangerup
Henrik Roed
Ib Jarle Christensen
Per Caye Thomasen
Juhler, Marianne

To evaluate long-term tumor control and hearing preservation rates in patients with vestibular schwannoma treated with fractionated stereotactic radiotherapy (FSRT), comparing hearing preservation rates to an untreated control group. The relationship between radiation dose to the cochlea and hearing preservation was also investigated.

Original language	English
Journal	International Journal of Radiation Oncology, Biology, Physics
Volume	83
Issue number	5
Pages (from-to)	e607-11
ISSN	0360-3016
DOIs	https://doi.org/10.1016/j.ijrobp.2012.01.078
Publication status	Published - 2012

ID: 48483250